Galderma Group N Enterprise Value to EBITDA (EV/EBITDA) on July 14, 2025: 41.24

Galderma Group N Enterprise Value to EBITDA (EV/EBITDA) is 41.24 on July 14, 2025, a 40.62% change year over year. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
  • Galderma Group N 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 44.40 on July 14, 2025, which is 7.67% above the current Enterprise Value to EBITDA (EV/EBITDA).
  • Galderma Group N 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 23.50 on July 14, 2025, which is -43.02% below the current Enterprise Value to EBITDA (EV/EBITDA).
  • Galderma Group N average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is 33.75.
Key Data
Date Enterprise Value to EBITDA (EV/EBITDA) Free Cash Flow Yield Dividend Yield Market Capitalization